These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 14760915)

  • 1. Mechanisms of termination of atrial fibrillation by Class I antiarrhythmic drugs: evidence from clinical, experimental, and mathematical modeling studies.
    Nattel S; Kneller J; Zou R; Leon LJ
    J Cardiovasc Electrophysiol; 2003 Oct; 14(10 Suppl):S133-9. PubMed ID: 14760915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of atrial fibrillation termination by rapidly unbinding Na+ channel blockers: insights from mathematical models and experimental correlates.
    Comtois P; Sakabe M; Vigmond EJ; Munoz M; Texier A; Shiroshita-Takeshita A; Nattel S
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1489-504. PubMed ID: 18676686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of atrial fibrillation termination by pure sodium channel blockade in an ionically-realistic mathematical model.
    Kneller J; Kalifa J; Zou R; Zaitsev AV; Warren M; Berenfeld O; Vigmond EJ; Leon LJ; Nattel S; Jalife J
    Circ Res; 2005 Mar; 96(5):e35-47. PubMed ID: 15731458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S
    Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potassium Channel Blockade Enhances Atrial Fibrillation-Selective Antiarrhythmic Effects of Optimized State-Dependent Sodium Channel Blockade.
    Aguilar M; Xiong F; Qi XY; Comtois P; Nattel S
    Circulation; 2015 Dec; 132(23):2203-11. PubMed ID: 26499964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological approaches in the treatment of atrial fibrillation.
    Tamargo J; Caballero R; Delpón E
    Curr Med Chem; 2004 Jan; 11(1):13-28. PubMed ID: 14754423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarization.
    Singh BN; Mody FV; Lopez B; Sarma JS
    Am J Cardiol; 1999 Nov; 84(9A):161R-173R. PubMed ID: 10568677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug therapy for termination of atrial fibrillation and maintenance of sinus rhythm.
    Talajic M; Roy D
    Can J Cardiol; 2005 Sep; 21 Suppl B():19B-25B. PubMed ID: 16239983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Past, Present, and Potential Future of Sodium Channel Block as an Atrial Fibrillation Suppressing Strategy.
    Aguilar M; Nattel S
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):432-40. PubMed ID: 25923324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class I or class III agents for atrial fibrillation: are asking the right question?
    Pacifico A; Henry PD
    Pacing Clin Electrophysiol; 2003 Jul; 26(7 Pt 2):1613-9. PubMed ID: 12914611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico optimization of atrial fibrillation-selective sodium channel blocker pharmacodynamics.
    Aguilar-Shardonofsky M; Vigmond EJ; Nattel S; Comtois P
    Biophys J; 2012 Mar; 102(5):951-60. PubMed ID: 22404917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of atrial fibrillation and action of drugs used in its management.
    Grant AO
    Am J Cardiol; 1998 Oct; 82(8A):43N-49N. PubMed ID: 9809900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiarrhythmic drugs in paroxysmal atrial fibrillation. When and how?].
    Lévy S; Ricard P; Yapo F; Mansouri C
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():19-24. PubMed ID: 8734159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part II: New insights into the electrophysiological mechanisms of atrial fibrillation termination.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):442-7. PubMed ID: 14558294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocardiographic and electrophysiological characteristics of atrial fibrillation organized into atrial flutter by oral administration of class I antiarrhythmic agents.
    Ohmura K; Kobayashi Y; Miyauchi Y; Endoh Y; Atarashi H; Katoh T; Takano T
    Pacing Clin Electrophysiol; 2003 Mar; 26(3):692-702. PubMed ID: 12698669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into mechanisms of antiarrhythmic drug action from experimental models of atrial fibrillation.
    Nattel S; Bourne G; Talajic M
    J Cardiovasc Electrophysiol; 1997 Apr; 8(4):469-80. PubMed ID: 9106433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic drug therapy for atrial fibrillation: focus on atrial selectivity and safety.
    Li D; Sun H; Levesque P
    Cardiovasc Hematol Agents Med Chem; 2009 Jan; 7(1):64-75. PubMed ID: 19149545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrocardiographic evidence of ventricular repolarization remodelling during atrial fibrillation.
    Tan HL; Smits JP; Loef A; Tanck MW; Hardziyenka M; Campian ME
    Europace; 2008 Jan; 10(1):99-104. PubMed ID: 18094018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Basic mechanisms of the new antiarrhythmic drugs in atrial fibrillation].
    Filgueiras-Rama D; Castrejón S; Calvo C; Estrada A; Doiny D; Ortega M; Berenfeld O; Merino JL; Jalife J
    Arch Cardiol Mex; 2012; 82(2):139-52. PubMed ID: 22735655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.